After counterfeit Avastin®--what have we learned and what can be done?
about
Glioma Stem Cells and Their Microenvironments: Providers of Challenging Therapeutic TargetsDigital danger: a review of the global public health, patient safety and cybersecurity threats posed by illicit online pharmacies.Bevacizumab in Colorectal Cancer: Current Role in Treatment and the Potential of Biosimilars.A review of existing and emerging digital technologies to combat the global trade in fake medicines.Public health interventions to protect against falsified medicines: a systematic review of international, national and local policies.The economics of counterfeit Avastin: a geospatial and statistical analysis of demographic correlates to FDA warning letters.Intravitreal administration of bevacizumab: pros and cons.
P2860
Q26765758-B39FAB30-3BC3-47AE-AA40-3803B6791175Q37451505-FFD37E77-E34F-4EB7-A944-95359CEEF2D4Q38643555-92DF7AED-1CEC-4A11-AD83-E345F9A7FEBCQ38738669-8533FBB6-5E6B-454A-A9A3-91004A4FF170Q38867438-A7CA4945-41DC-4BE8-B38F-D7D212E7A844Q39002113-F146BE2E-4CD3-42D6-9F44-36876D1861E3Q39865676-259B63EC-D330-4208-BEB9-1B0CC92235DC
P2860
After counterfeit Avastin®--what have we learned and what can be done?
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
After counterfeit Avastin®--what have we learned and what can be done?
@en
type
label
After counterfeit Avastin®--what have we learned and what can be done?
@en
prefLabel
After counterfeit Avastin®--what have we learned and what can be done?
@en
P2093
P2860
P1476
After counterfeit Avastin®--what have we learned and what can be done?
@en
P2093
Bryan A Liang
Camille Guerra
Raphael Cuomo
P2860
P304
P356
10.1038/NRCLINONC.2015.35
P407
P577
2015-03-03T00:00:00Z